Rankings
▼
Calendar
GERN FY 2023 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena
GERN
Geron Corporation
$1B
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$237,000
-60.2% YoY
Gross Profit
$237,000
100.0% margin
Operating Income
-$194M
-81832.9% margin
Net Income
-$184M
-77690.7% margin
EPS (Diluted)
$-0.32
Cash Flow
Operating Cash Flow
-$168M
Free Cash Flow
-$169M
Stock-Based Comp.
$19M
Balance Sheet
Total Assets
$394M
Total Liabilities
$146M
Stockholders' Equity
$248M
Cash & Equivalents
$70M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$237,000
$596,000
-60.2%
Gross Profit
$237,000
$596,000
-60.2%
Operating Income
-$194M
-$139M
-40.0%
Net Income
-$184M
-$142M
-29.8%
← Q4 2022
All Quarters
Q1 2023 →